S100A8 and major depressive disorder: It should be noted that the drugs administered, doses, and treatment times of the MDD + SSRIs group were very heterogeneous, and we need more studies in a larger cohort to clarify the effects of SSRIs on the expression of S100A8 in PBMCs of these patients.